Jennifer M. O'Toole

Medicine · Health Sciences

4h-index349citations27works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver physiology and pathology(21), Phagocytosis and Immune Regulation(18), Cancer Mechanisms and Therapy(11), Chronic Myeloid Leukemia Treatments(7), Herpesvirus Infections and Treatments(2)

Publications27 total

Supplementary Figure 5A and 5B from Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member
2023Open Access
Supplementary Figure 7A and 7B from Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member
2023Open Access
Supplementary Figure 6A and 6B from Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member
2023Open Access
Supplementary Figure 7A and 7B from Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member
2023Open Access
Supplementary Figure 1 from Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member
2023Open Access
Supplementary Figure 6A and 6B from Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member
2023Open Access
Supplementary Figure 2 from Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member
2023Open Access
Supplementary Figure Legends 1-7 from Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member
2023Open Access
Supplementary Figure Legends 1-7 from Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member
2023Open Access
Data from Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member
2023Open Access
Supplementary Figure 4 from Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member
2023Open Access
Supplementary Figure 1 from Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member
2023Open Access
Supplementary Figure 3 from Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member
2023Open Access
Supplementary Figure 4 from Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member
2023Open Access
Supplementary Figure 2 from Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member
2023Open Access
Supplementary Figure 3 from Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member
2023Open Access
Supplementary Figure 5A and 5B from Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member
2023Open Access
Data from Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member
2023Open Access
NUCLEOTIDYLATION TO ONCOAPOPTOSIS
WORLD SCIENTIFIC eBooks·2012
Abstract C54: In vitro and in vivo anti-tumor activity of the antimacrophage stimulating 1-receptor antibody IMC-RON8 in breast and bladder cancer models.
Molecular Cancer Therapeutics·2011· 2 cited
page 1 of 2Next →

Frequent Co-authors

Karen E. Rabenau(22), Dale L. Ludwig(22), Venkat Mangalampalli(20), Paul Balderes(20), Rajiv Bassi(20), Kerri Burns(19), Nicole Covino(19), Marie Prewett(19), Kimberly J. Gottfredsen(19), Megan N. Thobe(19), Yiwen Li(19), Daniel J. Hicklin(19), Zhenping Zhu(19), Susan E. Waltz(19), Michael J. Hayman(19), Dan Lu(18), Yuan Cheng(18), Daniel S. Pereira(14), Daniel S. Pereira(7), Martine Aubert(3)